Association between plasma fibroblast growth factor 23 and left ventricular mass index in patients with Takayasu arteritis

Racial/ethnic differences in the prognostic utility of left ventricular mass index for incident cardiovascular disease

(2018) Emmanuel Akintoye et al.   CLINICAL CARDIOLOGY

FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged AdultsNovelty and Significance

(2018) Ehimare Akhabue et al.   HYPERTENSION

Takayasu arteritis: advanced understanding is leading to new horizons

(2018) Enrico Tombetti et al.   RHEUMATOLOGY

Paracrine Effects of FGF23 on the Heart

(2018) Maren Leifheit-Nestler et al.   Frontiers in Endocrinology

Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults

(2018) Bhupesh Panwar et al.   JAMA Cardiology

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography

(2018) Carol Mitchell et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker

(2018) Przemyslaw Kotyla et al.   Journal of Clinical Medicine

Clinical Characteristics of Heart Involvement in Chinese Patients with Takayasu Arteritis

(2017) Jing Li et al.   JOURNAL OF RHEUMATOLOGY

Longitudinal FGF23 Trajectories and Mortality in Patients with CKD

(2017) Tamara Isakova et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Assessment of the frequency of cardiovascular risk factors in patients with Takayasu’s arteritis

(2017) Fatma Alibaz-Oner et al.   RHEUMATOLOGY

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

(2016) Valentin David et al.   KIDNEY INTERNATIONAL

Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease

(2016) Saurav Singh et al.   KIDNEY INTERNATIONAL

Cause of death in Chinese Takayasu arteritis patients

(2016) Jing Li et al.   MEDICINE

Expression of Fgf23 in Activated Dendritic Cells and Macrophages in Response to Immunological Stimuli in Mice

(2015) Yuki Masuda et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy

(2015) Alexander Grabner et al.   Cell Metabolism

Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease

(2015) Maren Leifheit-Nestler et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Diagnostic and classification criteria of Takayasu arteritis

(2014) Alexandre Wagner Silva de Souza et al.   JOURNAL OF AUTOIMMUNITY

Clinical Manifestations and Longterm Outcome for Patients with Takayasu Arteritis in China

(2014) L. Yang et al.   JOURNAL OF RHEUMATOLOGY

Fibroblast Growth Factor 23 and Inflammation in CKD

(2012) J. Munoz Mendoza et al.   Clinical Journal of the American Society of Nephrology

A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model

(2012) Bing Dai et al.   PLoS One

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis

(2010) William P. Arend et al.   ARTHRITIS AND RHEUMATISM

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION